Glenmark Pharmaceuticals informs about board meeting

29 Jul 2016 Evaluate

Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors will be held on August 12, 2016 to consider and approve the Company’s Unaudited Financial Statements for the First Quarter ended June 30, 2016 (Q1). Further, as per the ‘Code of Conduct for Prevention of Insider Trading’ of the Company, the trading window closed for Directors and other designated employees of the Company on June 25, 2016 and will remain closed up to August 16, 2016 for the purpose of approval of Unaudited Financial Statements for the First Quarter ended June 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

2006.90 -71.40 (-3.44%)
09-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1729.95
Dr. Reddys Lab 1209.45
Cipla 1466.15
Zydus Lifesciences 894.95
Lupin 2181.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×